Diamind Solutions


ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.

ESCAPE-NEXT is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:

  • Enables randomization of subjects based on a minimal sufficient balance algorithm
  • Provides the ability to record and store patient profiles
  • Provides drug management capabilities across multiple sites/locations
  • Provides functionality for validating the randomization of subjects
  • Provides an API integration with the IBM EDC solution
  • Provides a finance module for generating invoices based on patient enrollment and follow-up visits during the trial
  • Dashboards, charts and reports
  • Secure & Scalable

Want to know more about DCTMS? Please visit our DCTMS Product page or contact us for a free demo!

Other links:

Ready to enroll?Get started today!

Our main areas of expertise are in the Healthcare, Academic, Education as well as the Energy Sector, where we provide solutions for a number of needs:

  • - Clinical Trial Management Solutions (CTMS)
  • - Interactive Response Technologies (IRT)
  • - Randomization & Drug Management
  • - Document Management & eTMF
  • - eConsent
  • - EHR Integrations
  • - Custom Application Development
  • - Business Intelligence & Data Integration

Contact Us
App screenshot